A quick-reference infographic to connect antibody results → likely mycotoxins → body systems most affected → binders shown in research to help reduce burden
How to Read This
- Find your antibody result (IgE/IgG) to a mold or specific mycotoxin.
- Identify likely mycotoxin(s) associated with that mold.
- Match target body systems and common symptoms below.
- See potential binders with published affinity data.
- Reminder: Binders are supportive adjuncts; use under clinician guidance.
Quick Legend
- 🎯 Target Systems: organs or pathways most affected.
- 🧩 Key Mechanism: what the toxin tends to do at the cellular level.
- 🩺 Common Symptoms: frequently reported patterns (individuals vary).
- 🛡️ Binder Affinity: Evidence-based binding supports from chart (🟢 strong · 🟡 moderate · 🔴 weak · ⚪ speculative)
Aflatoxins (AFB₁ > others)
Producers: Aspergillus flavus, A. parasiticus
🎯 Target Systems: Liver (primary), GI, immune
🧩 Mechanism: Hepatotoxin; DNA adducts → carcinogenic risk
🩺 Symptoms: Nausea, fatigue; liver stress
🛡️ Binders: Activated Charcoal 🟢 · Bentonite Clay 🟢 · Zeolite 🟡 · Chlorella 🟡 · S. boulardii 🟡
Ochratoxin A (OTA)
Producers: Aspergillus ochraceus, A. carbonarius, Penicillium verrucosum
🎯 Target Systems: Kidneys, nervous system, liver
🧩 Mechanism: Nephrotoxic; oxidative stress
🩺 Symptoms: Polyuria, pain, brain fog
🛡️ Binders: Activated Charcoal 🟢 (88–100%) · Zeolite 🟡 · Chlorella 🟡 · S. boulardii 🟡 · Humic/Fulvic 🟢 · Glucomannan 🟡 · Chitosan 🟡
Trichothecenes (Satratoxin, Verrucarin, T-2, DON)
Producers: Stachybotrys, Fusarium spp.
🎯 Target Systems: Mucosa/skin, nervous system, immune
🧩 Mechanism: Ribotoxic stress → inflammation/apoptosis
🩺 Symptoms: Eye/skin burn, sore throat, cough, headache, fatigue
🛡️ Binders: Activated Charcoal 🟢 (>70%) · Glucomannan 🟡 (25–56%) · Chlorella 🟢 (DON) · S. boulardii 🟢 (DON, indirect)
Gliotoxin
Producers: Aspergillus fumigatus
🎯 Target Systems: Immune, liver, lungs
🧩 Mechanism: Immunosuppressive; induces apoptosis
🩺 Symptoms: Recurrent infections, chest tightness, fatigue
🛡️ Binders: Activated Charcoal 🟢 · Bentonite Clay 🟡 · Zeolite 🟡 · S. boulardii 🟢 · Chitosan 🟡
Zearalenone (ZEN)
Producers: Fusarium spp.
🎯 Target Systems: Endocrine/reproductive, liver
🧩 Mechanism: Estrogen mimic; endocrine disruption
🩺 Symptoms: Cycle irregularity, breast tenderness, libido/fertility issues
🛡️ Binders: Activated Charcoal 🟢 (93–100%) · Humic/Fulvic 🟢 (59–70%) · Zeolite 🟡 · S. boulardii 🟡 · Glucomannan 🟡 · Chitosan 🟡
Fumonisin B₁ (FB₁)
Producers: Fusarium verticillioides, F. proliferatum
🎯 Target Systems: Nervous system, kidneys, liver
🧩 Mechanism: Sphingolipid disruption → folate changes
🩺 Symptoms: Neuropathy, cognitive fog, kidney/liver stress
🛡️ Binders: Activated Charcoal 🟢 (~83%) · Bentonite Clay 🟡 (~32%) · Glucomannan 🟡 (25–45%) · Chitosan 🟡
Citrinin (CIT)
Producers: Penicillium, Aspergillus, Monascus spp.
🎯 Target Systems: Kidneys, liver, marrow
🧩 Mechanism: Nephrotoxic; additive with OTA
🩺 Symptoms: Polyuria, edema, fatigue
🛡️ Binders: Activated Charcoal 🟢 (broad-spectrum) · OTA binders synergistic
Patulin (PAT)
Producers: Penicillium expansum, some Aspergillus
🎯 Target Systems: GI tract, immune, kidneys
🧩 Mechanism: Electrophilic toxin; GI irritation
🩺 Symptoms: Nausea, vomiting, diarrhea, headache
🛡️ Binders: Activated Charcoal 🟢 (broad-spectrum) · Others ⚪ speculative
Sterigmatocystin
Producers: Aspergillus versicolor, precursor to aflatoxins
🎯 Target Systems: Liver, lungs, immune
🧩 Mechanism: Genotoxic, carcinogenic precursor
🩺 Symptoms: Similar to aflatoxin (liver stress, fatigue)
🛡️ Binders: Activated Charcoal 🟢 · Bentonite Clay 🟢 · Zeolite 🟡 · Chlorella 🟡 · S. boulardii 🟡
Mycophenolic Acid
Producers: Penicillium spp.
🎯 Target Systems: Immune (immunosuppressant), GI
🧩 Mechanism: Inhibits lymphocyte proliferation
🩺 Symptoms: Immunosuppression, infections, GI upset
🛡️ Binders: Activated Charcoal 🟢 (binds pharmaceutical form)
Cladosporium Toxin (HSP70 protein)
Producers: Cladosporium spp.
🎯 Target Systems: Immune/allergic pathways
🧩 Mechanism: Allergenicity via protein response
🩺 Symptoms: Allergy-like (rhinitis, asthma, atopy)
🛡️ Binders: ⚪ Speculative (no solid binder data; broad-spectrum charcoal may help)
Alternariol (AOH)
Producers: Alternaria spp.
🎯 Target Systems: Endocrine, genotoxic, immune (animal/in vitro data)
🧩 Mechanism: Estrogenic activity, oxidative stress
🩺 Symptoms: Hormone disruption, fatigue, allergy-like
🛡️ Binders: ⚪ No direct binder data; Activated Charcoal 🟢 (broad-spectrum, speculative)
Aspergillus Hemolysin
Producers: Aspergillus fumigatus and others
🎯 Target Systems: Immune/hematologic (hemolysis), lungs
🧩 Mechanism: Protein toxin disrupting membranes
🩺 Symptoms: Wheezing, immune reactivity, hemolysis (rare)
🛡️ Binders: ⚪ Speculative; broad-spectrum Activated Charcoal 🟢 may assist
SOURCES:
Mycotoxin Antibody Testing
- Mosaic Diagnostics (formerly MycoMETRIC Laboratory / MyMycoLab): The primary resource for the IgG and IgE antibody testing methodology and its clinical application. Their website and white papers explain the rationale behind using antibody detection over urinary excretion analysis for a more stable assessment of exposure and body burden.
- Gray, M. R., Thrasher, J. D., Crago, R., Madison, R. A., Arnold, L., Campbell, A. W., & Vojdani, A. (2003). Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings. Archives of environmental health, 58(7), 410–420. (This paper discusses the immunological responses to mold, underpinning the basis for antibody testing).
- Vojdani, A., & Hebroni, F. (2022). Molds, Mycotoxins, and their Immunotoxic Effects. Journal of Applied Bioanalysis, 8(3), 85-103.
General Mycotoxin Information and Sources
- World Health Organization (WHO). (2018). Mycotoxins. https://www.who.int/news-room/fact-sheets/detail/mycotoxins
- U.S. National Toxicology Program. Reports and monographs on various mycotoxins like Ochratoxin A and Fumonisin B1.
- Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical microbiology reviews, 16(3), 497–516. (A comprehensive academic overview of different mycotoxins and their producing fungi).
Binder Efficacy Studies and Reviews
The binding percentages in the chart are derived from a range of in vitro (laboratory) studies. Efficacy can vary based on the pH, mycotoxin concentration, and specific composition of the binder used.
Broad Reviews & Multiple Binders:
- Carballo, D. E., et al. (2019). Mycotoxin Binders: A Review of the Most Common Adsorbents and Their Mechanisms of Action. In Aflatoxin-Control, Analysis, and Health Effects. IntechOpen.
- Kolosova, A., & Stroka, J. (2011). Substances for reduction of the contamination of feed by mycotoxins. EFSA Supporting Publications, 8(11).
- Faucet-Marquis, V., et al. (2014). In vitro and in vivo evaluation of the mycotoxin-binding efficacy of a new mineral-based binder in beagle dogs. Journal of Applied Animal Nutrition, 3, e2.
Specific Binder Studies:
- Activated Charcoal:
- Galvano, F., et al. (1996). Activated carbons: in vitro affinity for ochratoxin A and deoxynivalenol and relation of adsorption ability to physicochemical parameters. Journal of Food Protection, 59(8), 845-850.
- Avantaggiato, G., et al. (2005). A new in vitro method to assess the efficacy of mycotoxin binding agents. Food and Chemical Toxicology, 43(1), 129-137.
- Clay (Bentonite, Zeolite):
- Daković, A., et al. (2005). Adsorption of ochratoxin A on organomodified natural zeolite. Colloids and Surfaces B: Biointerfaces, 46(1), 20-25.
- Huwig, A., et al. (2001). Mycotoxin detoxication of animal feed by different adsorbents. Toxicology letters, 122(2), 179-188. (This is a highly cited paper comparing the efficacy of different binders).
- Chlorella:
- Jub-Jub, G.N., et al. (2015). Chlorella pyrenoidosa supplementation on absorption and excretion of deoxynivalenol in piglets. Toxin Reviews, 34(3), 133-138.
- S. boulardii / Yeast Cell Wall:
- Shetty, P. H., & Jespersen, L. (2006). Saccharomyces cerevisiae and lactic acid bacteria as potential probiotics. FEMS Microbiology Reviews, 30(2), 270-281. (Discusses the binding mechanisms of yeast cell walls).
- Yiannikouris, A., et al. (2004). The effects of pH on the adsorption of zearalenone by β-d-glucans from Saccharomyces cerevisiae. Journal of Food Protection, 67(11), 2565-2570.
- Shashidhara, R., & Devegowda, G. (2003). Ability of modified glucomannan to reduce the toxic effects of gliotoxin in broiler chickens. Poultry Science, 82, 149. (This is a key source for Gliotoxin binding by yeast-derived components).
- Humic / Fulvic Acids:
- van Rensburg, C. J., et al. (2006). In vitro and in vivo assessment of the efficacy of a commercial mycotoxin binder against fumonisin B1 and zearalenone. Poultry science, 85(9), 1576-1583.
- Chitosan:
- Nezhad, A. S., et al. (2020). The potential of chitosan and its derivatives for mycotoxin adsorption in food and feed. Carbohydrate polymers, 231, 115735.